シェーグレン症候群(Sjogren’s Syndrome)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Sjogren’s Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Sjogren’s Syndrome to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Sjogren’s Syndrome to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Sjogren’s Syndrome 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Sjogren’s Syndrome Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Volution Immuno Pharmaceuticals (VIP) SA 33
Clinical Trial Overview of Volution Immuno Pharmaceuticals (VIP) SA 33
Parion Sciences, Inc. 34
Clinical Trial Overview of Parion Sciences, Inc. 34
Ferring International Center S.A. 35
Clinical Trial Overview of Ferring International Center S.A. 35
DENTAID, S.L. 36
Clinical Trial Overview of DENTAID, S.L. 36
Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
Aldeyra Therapeutics, Inc. 40
Clinical Trial Overview of Aldeyra Therapeutics, Inc. 40
Akorn, Inc. 41
Clinical Trial Overview of Akorn, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
National Institute of Dental and Craniofacial Research 42
Clinical Trial Overview of National Institute of Dental and Craniofacial Research 42
University Medical Center Groningen 43
Clinical Trial Overview of University Medical Center Groningen 43
National Institute of Arthritis and Musculoskeletal and Skin Diseases 44
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 44
Assistance Publique – Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 45
UMC Utrecht Holding BV 46
Clinical Trial Overview of UMC Utrecht Holding BV 46
University of Sao Paulo 47
Clinical Trial Overview of University of Sao Paulo 47
The National Institute of Allergy and Infectious Diseases 48
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48
Chiba University 49
Clinical Trial Overview of Chiba University 49
Kanazawa Medical University 50
Clinical Trial Overview of Kanazawa Medical University 50
National Institute of Environmental Health Sciences 51
Clinical Trial Overview of National Institute of Environmental Health Sciences 51
Five Key Clinical Profiles 52
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76